Perioperative Immunotherpay Versus Adjuvant Immunotherapy for Resectable Non-small Cell Lung Cancer

Clinical trial NCT06109402 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06109402
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Stage II-IIIB(N2) Non-small Cell Lung Cancer

Start date: 2023-12-20
Primary completion: 2030-11-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.